Immuneering (IMRX) Retained Earnings (2020 - 2024)
Immuneering (IMRX) has 5 years of Retained Earnings data on record, last reported at -$206.2 million in Q3 2024.
- For Q3 2024, Retained Earnings fell 39.19% year-over-year to -$206.2 million; the TTM value through Sep 2024 reached -$206.2 million, down 39.19%, while the annual FY2023 figure was -$163.3 million, 541927.15% down from the prior year.
- Retained Earnings reached -$206.2 million in Q3 2024 per IMRX's latest filing, down from -$1084.0 in the prior quarter.
- Across five years, Retained Earnings topped out at -$1084.0 in Q1 2024 and bottomed at -$206.2 million in Q3 2024.
- Average Retained Earnings over 5 years is -$65.1 million, with a median of -$44.2 million recorded in 2021.
- Peak YoY movement for Retained Earnings: plummeted 541927.15% in 2023, then skyrocketed 100.0% in 2024.
- A 5-year view of Retained Earnings shows it stood at -$25.7 million in 2020, then soared by 99.81% to -$49009.0 in 2021, then skyrocketed by 38.54% to -$30120.0 in 2022, then tumbled by 541927.15% to -$163.3 million in 2023, then dropped by 26.33% to -$206.2 million in 2024.
- Per Business Quant database, its latest 3 readings for Retained Earnings were -$206.2 million in Q3 2024, -$1084.0 in Q1 2024, and -$163.3 million in Q4 2023.